Publications 2024

Varela ML, Comba A, Faisal SM, Argento A, Peña Aguelo JA, Candolfi M, Castro MG, Lowenstein PR (2024)
Cell and gene therapy in neuro-oncology
Handb Clin Neurol, 205, 297-315
DOI 10.1016/B978-0-323-90120-8.00009-5, PubMed 39341660

Publications 2023

Comba A, Varela ML, Faisal SM, Abel CC, Argento AE, Al-Holou WN, Hollon TC, Perelman JD, Dunn PJ, Motsch S, Castro MG, Lowenstein PR (2023)
Generation of 3D ex vivo mouse- and patient-derived glioma explant slice model for integration of confocal time-lapse imaging and spatial analysis
STAR Protoc, 4 (2), 102174 (in press)
DOI 10.1016/j.xpro.2023.102174, PubMed 36930648

Publications 2022

Comba A, Faisal SM, Dunn PJ, Argento AE, Hollon TC, Al-Holou WN, Varela ML, Zamler DB, Quass GL, Apostolides PF, Abel C, Brown CE, Kish PE, Kahana A, Kleer CG, Motsch S, Castro MG, Lowenstein PR (2022)
Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progression
Nat Commun, 13 (1), 3606
DOI 10.1038/s41467-022-31340-1, PubMed 35750880

Faisal SM, Comba A, Varela ML, Argento AE, Brumley E, Abel C, Castro MG, Lowenstein PR (2022)
The complex interactions between the cellular and non-cellular components of the brain tumor microenvironmental landscape and their therapeutic implications
Front Oncol, 12, 1005069
DOI 10.3389/fonc.2022.1005069, PubMed 36276147

Hiraki HL, Matera DL, Wang WY, Prabhu ES, Zhang Z, Midekssa F, Argento AE, Buschhaus JM, Humphries BA, Luker GD, Pena-Francesch A, Baker BM (2022)
Fiber density and matrix stiffness modulate distinct cell migration modes in a 3D stroma mimetic composite hydrogel
Acta Biomater, 163, 378-391
DOI 10.1016/j.actbio.2022.09.043, PubMed 36179980

Varela ML, Comba A, Faisal SM, Argento A, Franson A, Barissi MN, Sachdev S, Castro MG, Lowenstein PR (2022)
Gene Therapy for High Grade Glioma: The Clinical Experience
Expert Opin Biol Ther, 23 (2), 145-161
DOI 10.1080/14712598.2022.2157718, PubMed 36510843

Publications 2021

Comba A, Dunn PJ, Argento AE, Kadiyala P, Ventosa M, Patel P, Zamler DB, Nunez FJ, Zhao L, Castro MG, Lowenstein PR (2021)
Erratum: Fyn tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates antiglioma immune responses
Neuro Oncol, 23 (8), 1413
DOI 10.1093/neuonc/noaa063, PubMed 32428217

Publications 2020

Comba A, Dunn PJ, Argento AE, Kadiyala P, Ventosa M, Patel P, Zamler DB, Núñez FJ, Zhao L, Castro MG, Lowenstein PR (2020)
Fyn tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates antiglioma immune responses
Neuro Oncol, 22 (6), 806-818
DOI 10.1093/neuonc/noaa006, PubMed 31950181